About Sun Pharma Laboratories Limited
Data last updated: 18 December 2025
Sun Pharma Laboratories Limited is a public limited company based in Vadodara, Gujarat, India, a subsidiary of Sun Pharmaceutical Industries Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 17 January 1997, the company has been in operation for over 29 years.
Registered with ROC Ahmedabad under CIN U25200MH1997PLC240268.
Capital: an authorised share capital of ₹90 Cr and a paid-up capital of ₹40.05 Cr. Formerly known as Sun Resins and Polymers Limited and Sun Resins and Polymers Private Limited. It is led by directors including Priti Paras Savla and Meetal Sharad Sampat.
Last AGM: 30 July 2025. Financial statements filed for year ended 31 March 2025. Office: Sun Pharma Advanced Research Centre (Sparc) Tandalja, Vadodara, Gujarat, India – 390012.
The company has a workforce of approximately 1,968 employees as per the latest available data. It operates as a subsidiary of Sun Pharmaceutical Industries Limited.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sunpharma.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media
-
Registered AddressSun Pharma Advanced Research Centre (Sparc) Tandalja, Vadodara, Gujarat, India – 390012
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Sun Pharma Laboratories Limited
Sun Pharma Laboratories Limited has undergone 2 name changes throughout its history. The company was previously known as Sun Resins And Polymers Limited, and Sun Resins And Polymers Private Limited. The current legal name is Sun Pharma Laboratories Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Sun Pharma Laboratories Limited | Current |
| Sun Resins And Polymers Limited | Previous |
| Sun Resins And Polymers Private Limited | Previous |
CIN History of Sun Pharma Laboratories Limited
Sun Pharma Laboratories Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U25200GJ1997PLC133846, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U25200GJ1997PLC133846 | Current |
| U25200MH1997PLC240268 | Previous |
| U25200GJ1997PLC031527 | Previous |
| U25200GJ1997PTC031527 | Previous |
Business Activity of Sun Pharma Laboratories Limited
Sun Pharma Laboratories Limited operates primarily in the electricity, gas, steam and air condition supply and manufacturing sectors. The company has 2 registered business activity segments, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| ********* | Electricity, gas, steam and air condition supply | ********* | Electric power generation, transmission and distribution | ********* |
| ********* | Manufacturing | ********* | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Board of Directors of Sun Pharma Laboratories Limited
Sun Pharma Laboratories Limited is currently managed by 8 directors, with 22 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Priti Paras Savla
Also directs:
Pitti Engineering Limited, Irb Infrastructure Developers Limited, Vikran Engineering Limited and 5 more
|
Director | 31 Oct 2022 | 3 Years 8 Months | Current |
|
Meetal Sharad Sampat
Also directs:
Sun Pharmaceutical Industries Limited, Realstone Infra Limited
|
Company Secretary | 27 May 2022 | 4 Years 1 Months | Current |
|
Rakeshchandra Jagdishprasad Sinha
Also directs:
Realstone Infra Limited, Zenotech Laboratories Limited, Caraco Pharmaceuticals Private Limited and 4 more
|
Director | 23 Apr 2024 | 2 Years 2 Months | Current |
| Kirti Wardhaman Ganorkar | Whole-Time Director | 21 May 2024 | 2 Years 1 Months | Current |
| Jayashree Satagopan | Cfo | 01 Jul 2025 | 1 Years 0 Months | Current |
|
Gautam Bhailal Doshi
Also directs:
Bhavna Doshi Associates Llp, Sun Pharmaceutical Industries Limited, Suzlon Energy Limited and 5 more
|
Director | 20 Oct 2021 | 4 Years 8 Months | Current |
Financials of Sun Pharma Laboratories Limited FY 2025 filings available
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings Sun Pharma Laboratories Limited
Sun Pharma Laboratories Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Sun Pharma Laboratories Limited
View historical data on people associated with Sun Pharma Laboratories Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Sun Pharma Laboratories Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Sun Pharma Laboratories Limited
GSTIN & GST Filing Data of Sun Pharma Laboratories Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Sun Pharma Laboratories Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Sun Pharma Laboratories Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Sun Pharma Laboratories Limited
MSME Payment Delays by Sun Pharma Laboratories Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Sun Pharma Laboratories Limited
Subsidiaries & Group Companies of Sun Pharma Laboratories Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Sun Pharma Laboratories Limited with ownership details.
MCA Filings & Documents of Sun Pharma Laboratories Limited
MCA Filings & Documents of Sun Pharma Laboratories Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Sun Pharma Laboratories Limited
Recent News on Sun Pharma Laboratories Limited
Frequently Asked Questions about Sun Pharma Laboratories Limited
Sun Pharma Laboratories Limited is an active public limited company in the pharma sector based in Vadodara, Gujarat, India. It was incorporated on 17 January 1997 (29+ years old) and is registered under CIN U25200GJ1997PLC133846. The company has 1,968 employees.
The current directors of Sun Pharma Laboratories Limited are:
- Priti Paras Savla
- Meetal Sharad Sampat
- Rakeshchandra Jagdishprasad Sinha
- Kirti Wardhaman Ganorkar
- Chinnadharavaram Sundaresan Muralidharan
- Kirti Wardhaman Ganorkar
- Jayashree Satagopan
- Gautam Bhailal Doshi
The primary industry of Sun Pharma Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Sun Pharma Laboratories Limited can be reached at the registered office: Sun Pharma Advanced Research Centre Sparc Tandalja, Vadodara, Gujarat, India – 390012, or through the website sunpharma.com.
The authorised capital is ₹90 Cr, and the paid-up capital is ₹40.05 Cr.
The company has its registered office at Sun Pharma Advanced Research Centre Sparc Tandalja, Vadodara, Gujarat, India – 390012.